Observational studyBMC pediatrics2026
Age-related differences in pediatric anaphylaxis: a single-center experience.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric anaphylaxis is a potentially life-threatening systemic hypersensitivity reaction with age-related differences in triggers and clinical manifestations. Real-life data are important to improve recognition, risk assessment, and management. This study aimed to evaluate the demographic and clinical characteristics, triggers, management, and factors associated with moderate-to-severe anaphylaxis in children, with particular emphasis on age-related differences.
methodsThis retrospective observational study was conducted at a pediatric allergy clinic between April 1, 2023, and July 1, 2025. Potential cases among children aged 0-18 years were identified using anaphylaxis-related ICD-10 codes and were subsequently re-evaluated according to the World Allergy Organization 2020 and European Academy of Allergy and Clinical Immunology 2021 diagnostic criteria. Demographic characteristics, triggers, clinical manifestations, treatment, clinical outcomes, and laboratory findings were analyzed.
resultsA total of 116 patients were included; 45 (38.8%) were female, and the mean age was 9.7 ± 5.9 years. Anaphylaxis most commonly occurred at home (66.4%), and oral exposure was the most frequent route of allergen exposure (67.2%). Foods were the most common triggers (42.2%), followed by drugs (37.1%) and Hymenoptera venom (12.9%). Tree nuts, cow's milk, and hen's egg were the leading food triggers. Food-induced anaphylaxis was significantly more frequent in children aged 0-5 years, whereas drug-induced reactions were more common in older children. Cardiovascular involvement was more frequent in patients aged ≥ 12 years and in Hymenoptera venom- and drug-induced reactions, whereas neurological involvement was more frequent in children aged 0-5 years. Hymenoptera venom-induced reactions had the shortest onset time (15 min [IQR, 5-30]). Intramuscular epinephrine was administered to 94.0% of patients. Moderate-to-severe anaphylaxis was observed in 64 patients. In multivariable logistic regression analysis, a history of food allergy was independently associated with moderate-to-severe anaphylaxis (OR, 5.08; 95% CI, 1.32-19.52; p = 0.018).
conclusionClinical manifestations and triggers of pediatric anaphylaxis varied according to age. Food-induced reactions were more common in younger children, whereas drug-induced reactions increased with age. A history of food allergy may indicate an increased risk for moderate-to-severe anaphylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.